Human Research Program Requirements Document (Revision C) by Vargas, Paul R.
HRP-47052 
Revision C  
Verify that this is the correct version. 
Human Research Program 
Requirements Document 
 
Human Research Program 
Revision C 
 
January 2009 
 
 
 
 
 
 
 
 
 
 
National Aeronautics and Space Administration 
Johnson Space Center 
Houston, Texas 
 
https://ntrs.nasa.gov/search.jsp?R=20090007829 2019-08-30T06:18:26+00:00Z
HRP-47052 
Revision C 
 ii 
Human Research Program 
Requirements Document 
January 2009 
 
 
PREFACE 
HUMAN RESEARCH PROGRAM REQUIREMENTS DOCUMENT 
This document is the Human Research Program Requirements Document. The 
purpose of this document is to define, document, and allocate HRP 
requirements. The need to produce a Program Requirements Document (PRD) is 
established in HRP-47051, Human Research Program - Program Plan, and is 
under configuration management control of the Human Research Program 
Control Board (HRPCB). 
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1. INTRODUCTION 
1.1 P UR P OS E  
The purpose of this document is to define, document, and allocate the Human 
Research Program (HRP) requirements to the HRP Program Elements. It 
establishes the flow-down of requirements from Exploration Systems Mission 
Directorate (ESMD) and Office of the Chief Health and Medical Officer (OCHMO) 
to the various Program Elements of the HRP to ensure that human research and 
technology countermeasure investments are made to insure the delivery of 
countermeasures and technologies that satisfy ESMD’s and OCHMO’s 
exploration mission requirements. 
1.2 S C OP E  
Requirements driving the HRP work and deliverables are derived from the 
exploration architecture, as well as Agency standards regarding the maintenance 
of human health and performance. Agency human health and performance 
standards will define acceptable risk for each type and duration of exploration 
mission. It is critical to have the best available scientific and clinical evidence in 
setting and validating these standards. In addition, it is imperative that the best 
available evidence on preventing and mitigating human health and performance 
risks is incorporated into exploration mission and vehicle designs. These 
elements form the basis of the HRP research and technology development 
requirements and highlight the importance of HRP investments in enabling 
NASA’s exploration missions. 
HRP requirements are derived from the Exploration Architecture Requirements 
Document (ESMD-EARD-08.07 Rev.-) – Section 4.4, ESMD Implementation Plan 
– Page 18, 1st paragraph (NP-2006-11-448-HQ), NASA Space Flight Human 
Systems Standards, Volume I: Crew Health (SFHSS Vol. 1), and NASA Space 
Flight Human Systems Standards, Volume II: Habitability and Environmental 
Health (SFHSS Vol. 2) 
This PRD defines the requirements of the HRP which is comprised of the following 
major Program Elements: Behavioral Health and Performance (BHP), Exploration 
Medical Capability (ExMC), Human Health Countermeasures (HHC), ISS Medical 
Project (ISSMP), Space Human Factors and Habitability (SHFH), and Space 
Radiation (SR). The requirements are divided into the following three categories:  
1) human system standards (section 4), 2) human health & performance risks 
(section 5) and 3) provisions of enabling capabilities (section 6) 
HRP requirements, as defined in this document, are allocated to the Program 
Office and its Program Elements. Where appropriate, the Program Elements 
further allocate requirements to their research and technology development 
projects. These allocations are documented in the Element/Project plans.  
Project plans describe specific endpoint deliverables that are linked to Project 
requirements. 
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1.3 C HANG E  AUT HOR IT Y  
This document is under Configuration Management control of the Human 
Research Program Control Board (HRPCB). Changes to this document will result 
in issuance of change pages or a full re-issue of the document. Review of the 
PRD will be performed and changes made as necessary to maintain consistency 
with the evolving ESMD strategies, goals, and objectives. 
2. DOCUMENTS 
2.1 AP P L IC AB L E  DOC UME NT S  
The following documents of the specified revision or the latest revision if not 
identified, are applicable to the extent specified herein. Inclusion of applicable 
documents herein does not in any way imply any order of precedence. 
Document 
No. 
Revision Document Title 
SFHSS Vol. 1  NASA Space Flight Human Systems 
Standards, Volume I: Crew Health 
SFHSS Vol. 2  NASA Space Flight Human Systems 
Standards, Volume II: Habitability and 
Environmental Health  
HRP-47051  Human Research Program – Program Plan 
NPD 1000.0 August 2005 NASA Strategic Management and 
Governance Handbook 
NPD 8500.1 Revision A NASA Environmental Management 
NPD 8910.1 Revision A Care and Use of Animals 
NPR 1080.1 February 2, 2005 NASA Science Management 
NPR 2190.1 April 10, 2003 NASA Export Control Program 
NPR 2810.1 August 26, 1999 Security of Information Technology 
NPR 5800.1 May 19, 2005 NASA Grant and Cooperative Agreement 
Handbook 
NPR 7100.1 March 28, 2003 Protection of Human Research Subjects 
NPR 7120.5 Revision C & D NASA Program and Project Management 
Processes and Requirements 
NPR 8000.4 April 25, 2002 Risk Management Procedural Requirements 
NPR 7123.1A March 26, 2007 NASA Systems Engineering Process and 
Requirements 
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2.2 R E F E R E NC E  DOC UME NT S  
The following documents contain supplemental information to guide the user in 
the application of this document. These reference documents may or may not be 
specifically cited within the text of the document. 
HRP-47065 HRP Integrated Research Plan 
NASA/SP-2004-6113 Bioastronautics Roadmap 
S.1281 National Aeronautics and Space Administration 
(NASA) Authorization Act of 2005 
NSPD31 National Security Presidential Directive 31 – The 
Vision for Space Exploration 
ESMD-EARD-08.07 Rev.- Exploration Architecture Requirements Document 
NP-2006-11-448-HQ ESMD Implementation Plan 
HRP-47053 HRP Science Management Plan 
HRP-470XX HRP Risk Evidence Book 
JSC 28330 SLSD Configuration Control Management Plan 
NPD 7100.8 Protection of Human Research Subjects 
3. HRP GOALS 
This section reflects the HRP Goals and Objectives described in the HRP 
Program Commitment Agreement and the HRP Program Plan (HRP 47051). 
3.1 THE GOAL OF THE HRP IS TO PROVIDE HUMAN HEALTH & 
PERFORMANCE COUNTERMEASURES, KNOWLEDGE, 
TECHNOLOGIES, & TOOLS TO ENABLE SAFE, RELIABLE, & 
PRODUCTIVE HUMAN SPACE EXPLORATION.  THE SPECIFIC 
OBJECTIVES OF THE HRP ARE: 
3.1.1 Develop capabilities, necessary countermeasures, and technologies in 
support of human space exploration, focusing on mitigating the highest 
risks to crew health and performance. Enable the definition and 
improvement of human spaceflight medical, environmental and human 
factors standards. 
3.1.2 Develop technologies that serve to reduce medical and environmental 
risks, to reduce human systems resource requirements (mass, volume, 
power, data, etc.) and to ensure effective human-system integration 
across exploration mission systems. 
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3.1.3 Ensure maintenance of Agency core competencies necessary to enable 
risk reduction in the following areas: space medicine, physiological and 
behavioral effects of long duration spaceflight on the human body, space 
environmental effects, including radiation, on human health and 
performance and space human factors. 
4. HRP REQUIREMENTS RELATED TO HUMAN SYSTEM 
STANDARDS  
4.1 THE HUMAN RESEARCH PROGRAM SHALL ENABLE THE 
DEVELOPMENT AND VALIDATION OF NASA’s HEALTH, 
MEDICAL, HUMAN PERFORMANCE, & ENVIRONMENTAL 
STANDARDS IN TIME FOR EXPLORATION MISSION PLANNING 
& DESIGN. 
Rationale: A first step in mitigation of human health and performance risks 
is the establishment of human spaceflight health standards. These 
standards are designed to address acceptable levels of human health risk 
for exploration missions of varying complexity and duration. The NASA 
Chief Health and Medical Officer has established an initial set of standards 
that serve to guide the Human Research Program in the expansion of 
evidence base regarding human spaceflight health and performance risks.   
HRP sponsors research and technology development enabling 
modification or development of OCHMO maintained standards. 
Several different types of standards have been established by the Chief 
Health and Medical Officer, and documented in Space Flight Human 
Systems Standards, Vol. 1 and Vol. 2. Specifically, the standards sets are 
listed below.   
• Fitness-for-duty standards for maintaining the physiological and 
behavioral parameters necessary to perform the required tasks; 
• Permissible outcome limits for the changes in health outcomes that are 
potentially affected by long-term exposure to the space environment;  
• Permissible exposure limits for managing risks by controlling human 
exposure; 
• Levels of care standards for guiding medical capabilities needed to 
respond to a medical contingency during exploration missions; and 
• Human factors and environmental standards to guide the development 
of spacecraft and systems so as to alleviate human health and 
performance impacts. 
• The Human Research Program requirements necessary to ensure the 
best possible evidence base in order to enable the development of 
standards are included in this section: 
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4.1.1 The HHC shall perform the research necessary to enable the development 
and validation of the Fitness for Duty Aerobic Capacity standard. 
4.1.2 The HHC shall perform the research necessary to enable the development 
and validation of the Fitness for Duty Sensorimotor standard. 
4.1.3 The HHC shall perform the research necessary to enable the development 
and validation of the Fitness for Duty Hematology and Immunology 
standard. 
4.1.4 The HHC shall perform the research necessary to enable the development 
and validation of the Permissible Outcome Limit for Nutrition standard. 
4.1.5 The HHC shall perform the research necessary to enable the development 
and validation of the Permissible Outcome Limit for Muscle Strength 
standard. 
4.1.6 The HHC shall perform the research necessary to enable the development 
and validation of the Permissible Outcome Limit for Microgravity Induced 
Bone Mineral Loss Performance standard. 
4.1.7 The HHC shall perform the research and ensure the technology 
availability to ensure the Levels of Care standards in pharmacology can 
be met for each exploration mission. 
4.1.8 The HHC shall perform the research and technology development 
necessary to enable the development of the Extravehicular Activity 
sections of the Spaceflight Human Systems Standard, Vol.2. 
4.1.9 The BHP shall perform the research necessary to enable the development 
and validation of the Fitness for Duty Behavioral Health and Cognition 
standard. 
4.1.10 The BHP shall perform the research necessary to enable the development 
of the Circadian Entrainment and Workload sections of the Spaceflight 
Human Systems Standard, Vol. 2. 
4.1.11 The SR shall perform the research necessary to enable development and 
validation of the Space Permissible Exposure Limit for Space Flight 
Radiation Exposure standard. 
4.1.12 The SR shall perform the research and technology developments 
necessary to enable the development of the Radiation sections of the 
Spaceflight Human Systems Standard, Vol. 2. 
4.1.13 The SHFH shall perform the research necessary to enable development 
and validation of the Permissible Exposure Limit Lunar Dust Inhalation 
standard. 
4.1.14 The ExMC shall perform the research necessary to enable development 
and validation of Crewmember Selection and Retention Criteria. 
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4.1.15 The SHFH shall perform the research and technology developments 
necessary to enable the development of the Spaceflight Human Systems 
Standard, Vol. 2. 
5. HRP REQUIREMENTS RELATED TO HUMAN HEALTH & 
PERFORMANCE RISKS 
The primary objective of the Human Research Program is to enable 
prevention and mitigation of human health and performance risks to enable 
successful completion of exploration missions, and preservation of 
astronaut health over the long-term.  
A key component of the HRP risk mitigation strategy is adoption of an 
occupational health model of managing astronaut health in the hazardous 
environment of space.  In this model, NASA seeks the most comprehensive 
evidence base possible, including medical data obtained over 40 years of 
space operations, and data obtained via research protocols.   
The HRP also seeks to strengthen its partnerships with international space 
agencies, National Space Biomedical Research Institute (NSBRI), ground 
based research clinicians in major medical centers, and the emerging 
commercial space transportation industry in order to provide the most 
extensive evidence base possible.  In this way, we will maximize our ability 
to understand and reduce health and performance risks. 
Per the HRP Program Plan, the Bioastronautics Roadmap (BR) was used 
as a starting-point reference document. The BR identifies risks, potential 
risks and areas of concerns, but it does not capture the level of detail 
necessary to prioritize across discipline or compare strategies for a given 
risk across mission architectures. Therefore, the Space Life Sciences 
Directorate developed the risk mitigation analysis tool (RMAT).  
The RMAT format reviews medical risks in terms of probability, impact, and 
proposals for mitigating the risks, and reviews each risk in terms of multiple 
mission architectures (short-duration Earth-orbital mission, ISS 6-month 
mission, ISS 12-month mission, short-duration Lunar sortie, long-duration 
Lunar mission, and Mars Mission).  Costs and risks are weighed against the 
probabilities of success of investing in developing a given risk mitigation 
proposal. This approach facilitates analysis of the risk across the different 
mission architectures and across underlying risk factors for a given 
architecture and will assist with resource allocation to address these risks. 
The HRP conducted an extensive review of medical research findings that 
led to the identification of a series of risks and contributing risk factors. Table 
1 contains items for which substantial evidence exists, while Table 2 
contains items of concern that cannot be supported or refuted by available 
information.   These risks and contributing factors are dynamic.  New risks 
may be identified with further mission experience, while some 
risks/contributing factors may be retired, if evidence is gathered that refutes 
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their importance.  The HRP shall periodically review available information 
and revise these risks/contributing factors as appropriate.   
As an example, future research may determine that microgravity exposure 
does not lead to heart rhythm disturbances, which would allow that risk to 
be retired.  To facilitate such reviews, the HRP will compile spaceflight 
medical research data in a centralized, well-cataloged and retrievable 
database.  The HRP will also strengthen partnerships with international 
space agencies, ground-based research clinicians in academic medical 
centers, and the commercial space transportation industry, to ensure that 
the spaceflight medical database is as complete and robust as possible.   
 
Table 1, Exploration Missions Human Health and Performance Risks Substantiated by 
a Strong Evidence Base 
Applicable 
HRP Element 
 
Risk and Risk Definition 
 
HHC 
Risk of Accelerated Osteoporosis 
Bone mineral loss occurs in microgravity due to unloading of the skeletal system, with 
average loss rates of approximately 1% per month.  It is unclear whether this bone 
mineral density will stabilize at a lower level, or continue to diminish.  It is unknown if 
fractional gravity, present on the moon and Mars would mitigate the loss; crewmembers 
could be at greater risk of osteoporosis-related fractures in later life. Greater 
understanding of the mechanisms of bone demineralization in microgravity is necessary 
to frame this risk, as well as to understand how current and future osteoporosis 
treatments may be employed. 
 
HHC 
Risk of Orthostatic Intolerance During Re-Exposure to Gravity 
Post-flight orthostatic intolerance, the inability to maintain blood pressure while in an 
upright position, is an established, space-related medical problem,   Countermeasures 
have been successfully identified and implemented (fluid loading, compression 
garments) or being evaluated (midodrine & others).  Completion of these efforts will be 
useful in determining what preventive measures should be used to combat orthostatic 
intolerance during future mission profiles. 
HHC Risk Factor of Inadequate Nutrition 
It is critical that crew members be adequately nourished before and during missions.  
Critical research areas within this risk include: validation of the correct nutritional needs; 
assessment of the stability of nutrients during long duration flight; correct packaging and 
preservation techniques; effects of countermeasures on nutrition; and use of nutrients 
as countermeasures. 
 
SHFH Risk of Inadequate Food System 
If the food system does not adequately provide for food safety, nutrition and taste, then 
crew health and performance and the overall mission may be adversely affected. 
Furthermore, if the food system uses more than its allocated mission resources, then 
total required mission resources may exceed capabilities, the mission deemed 
unfeasible, or allocation of resources to other systems may be unduly constrained. 
ExMC 
Mission architecture limits the amount of equipment and procedures that will be 
Risk of Inability to Adequately Treat an Ill or Injured Crew Member 
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Table 1, Exploration Missions Human Health and Performance Risks Substantiated by 
a Strong Evidence Base 
Applicable 
HRP Element 
 
Risk and Risk Definition 
available to treat medical problems.  Resource allocation and technology development 
must be performed to ensure that the limited mass, volume, power, and crew training 
time be efficiently utilized to provide the broadest possible treatment capability.  This 
allocation must also consider that not all medical conditions are treatable, given the 
limited resources, and some cases may go untreated. 
HHC Risk of Compromised EVA Performance and Crew Health Due to Inadequate EVA Suit 
Systems 
Improperly designed EVA suits can result in the inability of the crew to perform as 
expected, and can cause mechanical and decompression injury.  Suit developers must 
fully understand the impact of the suit design on crew performance and health to ensure 
properly designed mobility, pressures, nutrition, life support, etc. 
SHFH Risk of Error Due to Inadequate Information 
Information presentation, acquisition and processing significantly affect human task 
performance. Effective information availability directly impacts all aspects of 
communication, which is a vital element to all space missions.  Task errors during 
human spaceflight missions could have significant consequences to performance of 
mission objectives as well as human safety. Therefore further research regarding 
proper information presentation will allow for opportunities to optimize presentation 
of information, its timeliness, the user’s level of awareness of the information, 
modes of information presentation, proper information comprehension, training 
methods, and development of procedures 
BHP Risk of Behavioral and Psychiatric Conditions  
Behavioral issues are inevitable among groups of people, no matter how well selected 
and trained. Spaceflight demands can heighten these issues. The Institute of Medicine 
(IOM) report, Safe Passage, notes that Earth analog studies show an incidence rate of 
behavioral problems ranging from 3-13 percent per person per year. The report 
transposes these figures to 6-7 person crew on a 3-year mission to determine that there 
is a significant likelihood of psychiatric conditions emerging.  
Impacts of behavioral issues are minimized if they are identified and addressed early. 
The HRP must provide the best measures and tools to monitor and assess mood and to 
predict risk for and management of behavioral and psychiatric conditions prior, during 
and following spaceflight. 
BHP Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, 
and Work Overload 
Fatigue occurs during spaceflight and will jeopardize health and performance.  This risk 
may be influenced by artificial and transmitted light exposure, individual vulnerability to 
sleep loss and circadian dynamics, and work/sleep schedules.  Efforts are needed to 
improve sleep hygiene, and to identify and improve conditions that interfere with sleep 
quality.  Research areas may include: development of a self-assessment tool for 
cognitive function and fatigue, light therapy for phase shifting, alertness and mood 
disorders, and other means to improve sleep quality and reduce fatigue. 
SR 
Occupational radiation exposure from the space environment may increase cancer 
morbidity or mortality risk in astronauts. This risk may be influenced by other space 
Risk of Radiation Carcinogenesis 
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Table 1, Exploration Missions Human Health and Performance Risks Substantiated by 
a Strong Evidence Base 
Applicable 
HRP Element 
 
Risk and Risk Definition 
flight factors including microgravity and environmental contaminants. A Mars mission 
will not be feasible unless improved shielding is developed or transit time is decreased. 
SR Risk of Acute Radiation Syndromes Due to Solar Particle Events 
Radiation and synergistic effects of radiation may place the crew at significant risk for 
acute radiation sickness from a major solar event or artificial event, such that the 
mission or crew survival may be placed in jeopardy. Crew health and performance may 
be impacted by acute solar events. Beyond Low Earth Orbit, the protection of the 
Earth's atmosphere is no longer available, such that increased shielding and protective 
mechanisms are necessary in order to prevent acute radiation sickness and impacts to 
mission success or crew survival. The primary data available at present are derived 
from analysis of medical patients and persons accidentally exposed to high doses of 
radiation.  Data more specific to the spaceflight environment must be compiled to 
quantify the magnitude of increase of this risk and to develop appropriate protection 
strategies. 
SHFH Risk of Errors Due to Poor Task Design 
If roles and responsibilities for accomplishing tasks are not clearly defined, there will be 
a risk of serious errors of omission or commission. This risk may relate to interaction 
between multiple crew members, to interactions between crew and robotics / 
automation, and between crew and ground control. Understanding the characteristics of 
the elements involved, how each communicates, and establishing guidelines to adhere 
to during task design and procedure development are all essential to mission success.  
HHC Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance 
There is a growing research database which suggests that skeletal muscles, particularly 
postural muscles of the lower limb, undergo atrophy and structural and metabolic 
alterations during spaceflight.  However, the relationships between in-flight exercise, 
muscle changes and performance levels are not well understood. Efforts should be 
made to try to understand the current status of in-flight and post-flight exercise 
performance capability and what the goals/target areas for protection are with the 
current in-flight exercise program. 
 
Table 2, Exploration Missions Human Health and Performance Risks Requiring 
Further Evidence to Substantiate the Risk/Risk Factor 
Applicable 
HRP 
Element 
 
Risk and Risk Definition 
 
HHC Bone mineral loss occurs in microgravity due to unloading of the skeletal system, with 
average loss rates of approximately 1% per month.  It is unclear whether this bone 
mineral density will stabilize at a lower level, or continue to diminish.  It is also unknown if 
fractional gravity, present on the moon and Mars would mitigate the loss. This level of 
bone loss does not create an unacceptable risk of fractures for ISS missions, but longer 
Risk of Bone Fracture 
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Table 2, Exploration Missions Human Health and Performance Risks Requiring 
Further Evidence to Substantiate the Risk/Risk Factor 
Applicable 
HRP 
Element 
 
Risk and Risk Definition 
missions could create higher fracture risk. The risk of fracture during a mission cannot be 
accurately estimated until mechanisms and probabilities of bone overloading during the 
missions are understood.   Mission-related bone loss cannot be corrected by post-
mission rehabilitation; crewmembers could be at greater risk of osteoporosis-related 
fractures in later life. Greater understanding of the mechanisms of bone demineralization 
in microgravity is necessary to frame this risk, as well as to understand how current and 
future osteoporosis treatments may be employed. 
 
HHC 
Risk of Intervertebral Disc Damage 
Extended exposures to microgravity (and possibly fractional gravity) may lead to an 
increased risk of spinal nerve compression and back pain. 
 
HHC 
Risk of Renal Stone Formation 
Kidney stone formation and passage has the potential to greatly impact mission success 
and crewmember health for long duration missions.   Alterations in hydration state 
(relative dehydration) and bone metabolism (increased calcium excretion) during 
exposure to microgravity may increase the risk of kidney stone formation and it is unclear 
which mitigation strategy would be the most effective.  
 
HHC 
Risk of Cardiac Rhythm Problems 
Heart rhythm disturbances have been seen among astronauts.  Most of these have been 
related to cardiovascular disease, but it is not clear whether this was due to pre-existing 
conditions or effects of spaceflight.  It is hoped that advanced screening for coronary 
disease has greatly mitigated this risk.  Other heart rhythm problems, such as atrial 
fibrillation, can develop over time, necessitating periodic screening of crewmembers’ 
heart rhythms.  Beyond these terrestrial heart risks, some concern exists that prolonged 
exposure to microgravity may lead to heart rhythm disturbances.  Although this has not 
been observed to date, further surveillance is warranted. 
 
HHC 
Risk of Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity 
Astronauts’ physical performance during a mission, including tasks in microgravity and 
fractional gravity, is critical to mission success   Setting minimum fitness standards and 
measuring whether crew can maintain these standards will document the effectiveness of 
maintenance regimens.   
 
SHFH 
Risk of Adverse Health Effects from Lunar Dust Exposure 
The toxicological effects of lunar dusts have not been studied in sufficient depth to 
develop an exposure standard for operations on the lunar surface.  Lunar dusts have a 
high content in the respirable size range, they have a high surface area that is chemically 
reactive, and elemental iron "nano-particles" are imbedded in the dust grains. These 
unusual properties may cause the respirable dusts to be at least moderately toxic to the 
respiratory system, and larger grains to be abrasive to the skin & eye. NASA needs to set 
an airborne exposure standard based on scientific evidence so that vehicle designs can 
effectively control exposure.  
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Table 2, Exploration Missions Human Health and Performance Risks Requiring 
Further Evidence to Substantiate the Risk/Risk Factor 
Applicable 
HRP 
Element 
 
Risk and Risk Definition 
 
HHC 
Risk of Crew Adverse Health Event Due to Altered Immune Response 
Human immune function is altered in- and post-flight, but it is unclear if this change leads 
to an increased susceptibility to disease.  Reactivation of latent viruses has been 
documented in crewmembers, though this reactivation has not been directly correlated 
with the immune changes nor with observed disease.  Further research may elucidate 
whether microgravity exposure impairs the immune system, and whether this change 
represents a health risk to crews. 
HHC Risk of Impaired Ability to Maintain Control of Vehicles and Other Complex Systems 
It has been shown that long duration Spaceflight alters sensorimotor function which 
manifests as changes in locomotion, gaze control, dynamic visual acuity, and perception. 
These changes have not specifically been correlated with real time performance 
decrements.  The possible alterations in sensorimotor performance are of interest for 
Mars missions due to the prolonged microgravity exposure during transit followed by 
landing tasks. This risk must be better documented and NS changes must be better 
correlated with performance issues. 
HHC Risk of Therapeutic Failure Due to Ineffectiveness of Medication 
Based on subjective reports, drugs are effective during spaceflight.  Better recordkeeping 
of medication use, efficacy and side effects will be instituted and those records will 
provide evidence for or against this risk.  If medications are found to be ineffective, 
research will be performed to determine if drug metabolism is affected by spaceflight.  
Studies to determine if spaceflight affects drug stability are currently underway. 
BHP Risk of Performance Errors Due to Poor team Cohesion and Performance, Inadequate 
Selection/Team Composition, Inadequate Training, and Poor Psychosocial Adaptation 
Human performance errors may occur due to problems associated with working in the 
space environment and incidents of failure of crews to cooperate and work effectively 
with each other or with flight controllers have been observed.  Interpersonal conflict, 
misunderstanding and impaired communication will impact performance and mission 
success.  The history of spaceflight crews regarding team cohesion, training and 
performance has not been systematically documented.  Tools, training and support 
methods should be provided to reduce the likelihood of this risk and improve crew 
performance. 
SR Risk of Acute or Late Central Nervous System Effects from Radiation Exposure 
Acute and late radiation damage to the central nervous system (CNS) may lead to 
changes in motor function and behavior, or neurological disorders. Radiation and 
synergistic effects of radiation with other space flight factors may affect neural tissues, 
which in turn may lead to changes in function or behavior. Data specific to the spaceflight 
environment must be compiled to quantify the magnitude of this risk.  If this is identified 
as a risk of high enough magnitude then appropriate protection strategies should be 
employed.   
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Table 2, Exploration Missions Human Health and Performance Risks Requiring 
Further Evidence to Substantiate the Risk/Risk Factor 
Applicable 
HRP 
Element 
 
Risk and Risk Definition 
SR Risk of Degenerative Tissue or other Health Effects from Radiation Exposure 
Occupational radiation exposure from the space environment may result in degenerative 
tissue diseases (non-cancer or non-CNS) such as cardiac, circulatory, or digestive 
diseases, as well as cataracts, although the mechanisms and the magnitude of influence 
of radiation leading to these diseases are not well characterized. Radiation and 
synergistic effects of radiation cause increased DNA strand and tissue degeneration, 
which may lead to acute or chronic disease of susceptible organ tissues. Data specific to 
the spaceflight environment must be compiled to quantify the magnitude of this risk to 
determine if additional protection strategies are required.   
SHFH Risk of Reduced Safety and Efficiency Due to an Inadequately Designed Vehicle, 
Environment, Tools or Equipment 
The habitability of the architecture, habitable environment, tools, and equipment is critical 
for the existence of humans in space. Any inadequacies in the design of the environment 
or architecture can restrict or prevent the user from surviving in such extreme conditions 
and may impact safety and performance. Factors that affect the habitability must be 
assessed and properly addressed to ensure all potential hazards are mitigated or 
monitored.  If the workspace, equipment and tools are not designed to be usable by the 
full range of crew members, and are not properly laid out, the likelihood of errors or crew 
inability to complete a task in a timely manner increases.  Inconsistent design among 
subsystems and vehicles leads to negative transfer of training and increased likelihood of 
errors. 
SHFH Risk of Adverse Health Effects Due to Alterations in Host-Microorganism Interactions 
While hazard control systems and processes are in place to limit the presence of 
many medically significant microorganisms during a mission, crewmembers and 
other items carry a host of organisms with them, thus microbial infection of 
crewmembers cannot be completely prevented. Recent evidence from spaceflight 
experiments also suggests alterations in microbial characteristics, including virulence 
(disease causing potential), in organisms grown during flight. There is insufficient 
evidence to determine whether these observed alterations are clinically significant.  
These observations indicate greater uncertainty in our ability to evaluate infectious 
disease risk to the crew during flight. 
 
5.1 THE HRP SHALL QUANTIFY THE HUMAN HEALTH & 
PERFORMANCE RISKS ASSOCIATED WITH HUMAN 
SPACEFLIGHT FOR EXPLORATION MISSIONS. 
Rationale: In many cases, there is a large uncertainty associated with the 
risk due to lack of controlled spaceflight (or ground analog) experimental 
evidence. This HRP requirement is to quantifiably describe the likelihood 
and consequences of the risks. The uncertainties associated with these 
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quantities should be narrowed to the target values identified by each 
standard or to the greatest extent practical to facilitate proper decisions for 
exploration hardware design and mission design. 
5.1.1 The HRP Science Management Office (SMO) shall develop ways to 
improve estimates of the integrated human health and performance risk 
associated with human spaceflight for exploration missions.  
Rationale: The overall risk assessment extends beyond a “list” of risks.  
The risks often have inter-relationships and interdependencies.  The SMO 
must evaluate the risks to identify and quantify these inter-relationships 
and interdependencies, and provide an assessment of the total risk to the 
human system for spaceflight. This will help focus the HRP effort and 
ensure proper decision making. 
5.1.2 The BHP shall quantify the BHP-applicable Risks identified in Tables 1 & 2. 
5.1.3 The ExMC shall quantify the ExMC-applicable Risks identified in Tables 1 & 2. 
5.1.4 The HHC shall quantify the HHC-applicable Risks identified in Tables 1 & 2. 
5.1.5 The SHFH shall quantify the SHFH-applicable Risks identified in Tables 1 & 2. 
5.1.6 The SR shall quantify the Space Radiation-applicable Risks identified in Tables 
1 & 2. 
 
5.2 THE HRP ELEMENTS SHALL DEVELOP COUNTERMEASURES 
& TECHNOLOGIES TO PREVENT OR MITIGATE ADVERSE 
OUTCOMES OF HUMAN HEALTH & PERFORMANCE RISKS. 
Rationale: Each risk is written with respect to an adverse outcome.  The 
intent of the HRP is to prevent the adverse outcome from occurring.  If that 
cannot be done, the intent is to develop and validate novel 
countermeasures (devices, drugs, procedures, etc) that will mitigate the 
adverse outcome. In this context, “mitigate” means “reduce the severity or 
reduce the probability of the adverse outcome.” 
5.2.1 The BHP shall develop countermeasures and technologies to prevent or 
mitigate adverse outcomes of human health and performance risks 
relevant to BHP (see Tables 1 & 2). 
5.2.2 The ExMC shall develop countermeasures and technologies to prevent or 
mitigate adverse outcomes of human health and performance risks 
relevant to ExMC (see Tables 1 & 2). 
5.2.3 The HHC shall develop countermeasures and technologies to prevent or 
mitigate adverse outcomes of human health and performance risks 
relevant to HHC (see Tables 1 & 2). 
5.2.4 The SHFH shall develop countermeasures and technologies to prevent or 
mitigate adverse outcomes of human health and performance risks 
relevant to SHFH (see Tables 1 & 2). 
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5.2.5 The SR shall develop countermeasures and technologies to prevent or 
mitigate adverse outcomes of human health and performance risks 
relevant to Space Radiation (see Tables 1 & 2). 
 
5.3 THE HRP ELEMENTS SHALL DEVELOP COUNTERMEASURES 
& TECHNOLOGIES TO MONITOR & TREAT ADVERSE 
OUTCOMES OF HUMAN HEALTH & PERFORMANCE RISKS. 
Rationale: If a risk cannot be mitigated adequately, the human must be 
monitored for indicators of an adverse outcome, and treatment and or 
countermeasures should be developed. 
5.3.1 The BHP shall develop countermeasures and technologies to monitor and 
treat adverse outcomes of human health and performance risks relevant 
to BHP (see Tables 1 & 2). 
5.3.2 The ExMC shall develop countermeasures and technologies to monitor 
and treat adverse outcomes of human health and performance risks 
relevant to ExMC (see Tables 1 & 2). 
5.3.3 The HHC shall develop countermeasures and technologies to monitor and 
treat adverse outcomes of human health and performance risks relevant 
to HHC (see Tables 1 & 2). 
5.3.4 The SHFH shall develop countermeasures and technologies to monitor 
and treat adverse outcomes of human health and performance risks 
relevant to SHFH (see Tables 1 & 2). 
5.3.5 The SR shall develop countermeasures and technologies to monitor and 
treat adverse outcomes of human health and performance risks relevant 
to Space Radiation (see Tables 1& 2). 
6. HRP REQUIREMENTS RELATED TO PROVISION OF 
ENABLING CAPABILITIES 
6.1 THE HRP SHALL PROVIDE THE ENABLING CAPABILITY TO 
FACILITATE HUMAN SPACE EXPLORATION WITH RESPECT 
TO THE HUMAN SYSTEM. 
Rationale: Ensuring Human exploration requires some infrastructure or 
activities that do not readily fall into a specific research and technology 
development category. The requirements below are intended to provide 
NASA with the necessary infrastructure or capabilities to implement the 
research and technology work required to update inform and validate 
standards and to address the risks relevant to human exploration. 
In the course of research and technology development, each HRP 
Element may encounter the need to perform studies in a ground-based 
space analog environment (e.g. bed-rest facility, Antarctica, NEEMO).  
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Each Element is responsible for the selection and/or validation of the 
appropriate analogs and the necessary planning, integration and 
execution. Large resource commitments to analog facilities must be 
reflected in the Element Research Plan so that the cost-benefit to the HRP 
is clear. 
6.1.1 The ISSMP shall plan, integrate, and execute HRP research tasks 
requiring access to space to address standards or reduce or eliminate 
human health and performance risks. 
Rationale: Access to space research platforms, namely the Space 
Transportation System (STS), the ISS and the Crew Exploration Vehicle 
(CEV) (transport to and from the ISS) is required to study and/or validate 
many of the items in sections 4.1 and 5.0.  The ISSMP serves as the 
service to integrate, across all other HRP Elements, and optimize the 
research plans requiring access to space. The ISSMP provides the 
interface to the spaceflight programs to ensure that the research is 
properly planned, integrated and executed with the required data returned 
to the investigator. 
6.1.2 The ExMC shall provide data integration and management function to 
ensure proper handling of and access to HRP data. 
Rationale: Access to data is critically important to advancing the state of 
knowledge of the human system in space. A data integration and 
management function includes the proper archiving of historical research 
data (e.g. The Life Science Data Archive), and organizing medical and 
research data to provide proper security levels, allow queriable access,  
and to provide tools to allow analysis of evidence (e.g. Integrated Medical 
Model). 
6.2 THE HRP SHALL ENSURE PRESERVATION & MAINTENANCE 
OF CORE TECHNICAL CAPABILITY & EXPERTISE IN HUMAN 
RESEARCH & TECHNOLOGY DEVELOPMENT. 
Rationale: The core competencies are those which are necessary to 
maintain and nurture an understanding of the existing evidence base 
regarding risks and adverse outcomes to humans due to spaceflight. This 
core competency involves sustaining and maintaining a dedicated 
workforce and a robust external scientific community. It also requires 
adequate testing laboratory physical plant capability. Preservation and 
maintenance of this capability is necessary to provide stability over the 
multi-decadal implementation of the vision for space exploration. This core 
competency is necessary to facilitate: 
Strategic Planning. Identifying, prioritizing the risks to the human system 
and developing long-range plans to quantify, prevent, mitigate, and treat 
the adverse outcomes requires competency of both the internal and 
external community to ensure proper direction to the research community 
for focusing their effort.  
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Acquisition development, planning and execution. Acquisition of research 
and technology development is an inherently government function that 
requires core expertise within the civil service to ensure that the US 
Government remains a “smart buyer” with respect to research and 
technology development for the human system. 
Operations support for near-real time and real-time operational decisions 
involving the human system and environment. Laboratory facilities and the 
expertise to run them and interpret results are necessary to support an 
ongoing evaluation of the human system response to the space 
environment, and to support the medical operations function during a 
mission. This involves the internal community, and to some extent the 
external community where uniquely specialized expertise must be sought. 
The requirement is written at the HRP level and not specifically allocated 
to the Program Elements.  The Program Manager will periodically review 
the core technical capability of the Program Elements and adjust where 
appropriate. 
6.3 EACH HRP ELEMENT SHALL ENSURE THAT THEIR 
PROCESSES & PRODUCTS COMPLY WITH THE NASA POLICY 
DIRECTIVES & NASA PROCEDURAL REQUIREMENTS LISTED 
IN THE TABLE OF APPLICABLE DOCUMENTS IN SECTION 2.1. 
Rationale: The Table of applicable documents includes the NPDs and 
NPRs specifically referenced by the HRP Program Plan (HRP 47051). 
This requirement explicitly states which NPRs and NPDs are applicable to 
the HRP, and ensures that the requirement is flowed down to the Program 
Element level. Identification of specific NPR/NPD applicability falls upon 
each individual Element/Project when the Project Plan is defined. The 
intent of this requirement is to ensure HRP compliance with these 
documents within the normal processes and product development ongoing 
in the HRP. 
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6.4 THE HRP ELEMENTS SHALL DEVELOP METHODS AND 
TECHNOLOGIES TO REDUCE HUMAN SYSTEMS RESOURCE 
REQUIREMENTS (MASS, VOLUME, POWER, DATA, ETC.). 
Rationale: Methods and technologies that reduce the medical systems 
requirements for mass, volume, power, data, etc. must be developed to 
reduce the overall Constellation Program resource requirements. Each 
HRP research element must focus the research on producing 
countermeasures and technologies that fit within the extremely limited 
resource envelopes anticipated for the exploration mission. An example is 
the reduction in time dedicated to exercise prescriptions. Present exercise 
prescriptions present a large burden on the overall mission timeline.  
6.4.1 The HHC shall develop methods and technologies to reduce human 
systems resource requirements (mass, volume, power, data, etc.). 
6.4.2 The BHP shall develop methods and technologies to reduce human 
systems resource requirements (mass, volume, power, data, etc.). 
6.4.3 The SR shall develop methods and technologies to reduce human 
systems resource requirements (mass, volume, power, data, etc.). 
6.4.4 The SHFH shall develop methods and technologies to reduce human 
systems resource requirements (mass, volume, power, data, etc.). 
6.4.5 The ExMC shall develop methods and technologies to reduce human 
systems resource requirements (mass, volume, power, data, etc.). 
 
 
HRP-47052 
Revision C 
18 
APPENDIX A  ACRONYMS AND ABBREVIATIONS 
 
BHP Behavioral Health & 
Performance 
BMD Bone Mineral Density 
CEV Crew Exploration Vehicle 
CM Configuration Management 
CMS Competency Management 
System 
Cx Constellation 
E.G. For Example 
ESMD Exploration Science Mission 
Directorate 
EVA Extravehicular Activity 
ExMC Exploration Medical Capabilities 
HHC Human Health Countermeasures 
HRP Human Research Program 
HRPCB Human Research Program 
Control Board 
IOM Institute of Medicine 
IRP Integrated Research Plan 
ISS International Space Station 
ISSMP ISS Medical Project 
IVA Intravehicular Activity 
JSC Johnson Space Center 
Lab Laboratory 
NASA National Aeronautics and Space 
Administration 
NEEMO NASA Extreme Environment 
Mission Operations 
NGO Needs, Goals, Objectives 
NP NASA Publication 
NPD NASA Procedural Directive 
NPR NASA Procedural Requirements 
NSBRI National Space Biomedical 
Research Institute 
NSPD National Security Presidential 
Directive 
NSTS National Space Transportation 
System 
OCHMO Office of the Chief Health and 
Medical Office 
PIO Program Integration Office 
PRD Program Requirements 
Document 
RMAT Risk Mitigation Analysis Tool 
SA Space Life Sciences 
Directorate 
SAT Small Assessment Team 
SD Space Medicine Division 
SHFH Space Human Factors & 
Habitability 
SFHCS Space Flight Health Care 
Standard 
SFHSS Space Flight Human System 
Standard 
SLSD Space Life Sciences 
Directorate 
SMO Science Management Office 
SMP Science Management Plan 
SR Space Radiation 
SSP Space Station Program 
STS Space Transportation System 
TBD To Be Determined 
U.S. United States 
 
